PCG
TEVA icon

Private Capital Group’s Teva Pharmaceuticals TEVA Stock Holding History

Private Capital Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$0 Hold
54
– – ﹤0.01% 2102
2022
Q1 		$1K Hold
54
– – ﹤0.01% 2005
2021
Q4 		$0 Sell
54
-18
-25% -$162 ﹤0.01% 2191
2021
Q3 		$1K Sell
72
-626
-90% -$5.86K ﹤0.01% 2057
2021
Q2 		$7K Buy
698
+26
+4% +$275 ﹤0.01% 1480
2021
Q1 		$8K Sell
672
-1,156
-63% -$13.3K ﹤0.01% 1376
2020
Q4 		$18K Buy
1,828
+1,756
+2,439% +$16.8K ﹤0.01% 1227
2020
Q3 		$1K Sell
72
-7
-9% -$74 ﹤0.01% 1892
2020
Q2 		$1K Sell
79
-132
-63% -$1.49K ﹤0.01% 1883
2020
Q1 		$2K Buy
211
+24
+13% +$246 ﹤0.01% 1710
2019
Q4 		$1K Hold
187
– – ﹤0.01% 1861
2019
Q3 		$1K Sell
187
-144
-44% -$1.1K ﹤0.01% 2098
2019
Q2 		$8K Buy
+331
New +$3.99K ﹤0.01% 1485
2019
Q1 		– Sell
-131
Closed -$2K – 2311
2018
Q4 		$2K Sell
131
-200
-60% -$4.1K ﹤0.01% 1921
2018
Q3 		$7K Hold
331
– – ﹤0.01% 1596
2018
Q2 		$8K Buy
331
+200
+153% +$4.08K ﹤0.01% 1502
2018
Q1 		$2K Sell
131
-187
-59% -$3.65K ﹤0.01% 1870
2017
Q4 		$6K Buy
+318
New +$4.78K ﹤0.01% 1591

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Private Capital Group's TEVA Position: Q2 2022 in Review

Private Capital Group held its Teva Pharmaceuticals (TEVA) position steady in Q2 2022 at 54 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Private Capital Group first reported a position in TEVA in Q4 2017 and has held it in 18 quarters since. The position peaked at $18K in Q4 2020. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2022.

  • Private Capital Group held 54 shares of Teva Pharmaceuticals worth $0 as of Q2 2022.
  • Private Capital Group left its Teva Pharmaceuticals share count unchanged in Q2 2022.
  • Teva Pharmaceuticals made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #2102 holding.
  • Private Capital Group first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 18 quarters since.
  • Private Capital Group's Teva Pharmaceuticals position peaked at $18K in Q4 2020.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.